Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Air Waste Manag Assoc ; 70(7): 721-728, 2020 07.
Artigo em Inglês | MEDLINE | ID: mdl-32412353

RESUMO

Gaseous chlorine dioxide (ClO2) is one of the most promising air disinfectants. In this study, an ultra-low concentration of ClO2 gas (< 1.2 mg/m3) was generated in an office at various levels of humidity and illuminance to investigate the decay law. The disinfection efficiency and metal corrosiveness of ultra-low concentrations of ClO2 gas were also studied using an experimental chamber. At 48% and 75% humidity, the decay rate constants of ClO2 gas were 0.0034 min-1 and 0.0036 min-1, respectively. The rate of decline of the ClO2 concentration increased as the humidity of the environment increased. The decay rate constant of ClO2 gas at an illuminance of 76 lux and 3429 lux was 0.0034 min-1 and 0.00427 min-1, respectively; hence, the decay rate increased with increased illumination. At a humidity of 72% and illuminance of 2112 lux, the decay rate constant reached 0.00880 min-1. The effects of humidity and illuminance on the attenuation of the ClO2 concentration were strongly synergistic. When the gas concentration was maintained below 0.9 mg/m3, the disinfection rate of ClO2 on bacteria (P. aeruginosa, V. mimicus and S. aureus) exceeded 99.9%; thus, ClO2 gas exhibited a high disinfection efficiency. In addition, there was no corrosion to various metals by ClO2 under the same conditions. Consequently, gaseous ClO2 at ultra-low concentrations has a high sterilization efficiency and is non-corrosive to metals. IMPLICATIONS: Humidity and illuminance can influence decay laws of extremely low concentration ClO2 gas. The gaseous ClO2 at ultra-low concentrations has a high sterilisation efficiency and is non-corrosive to metals.


Assuntos
Compostos Clorados/farmacologia , Desinfetantes/farmacologia , Desinfecção/métodos , Óxidos/farmacologia , Pseudomonas aeruginosa/efeitos dos fármacos , Staphylococcus aureus/efeitos dos fármacos , Vibrio mimicus/efeitos dos fármacos , Poluição do Ar em Ambientes Fechados/prevenção & controle , Umidade
2.
PLoS One ; 11(11): e0165092, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27832083

RESUMO

Vibrio mimicus is a pathogen that causes ascites disease in fish. We have previously demonstrated that the outer membrane protein U (OmpU) is an important adhesin in V. mimicus. Here eight specific OmpU-binding phage clones, which presented three different OmpU-binding peptides (designated P1, P2, P3), were screened from a commercially available phage displayed 12-mer peptide library using rOmpU protein as target. Then, synthetic OmpU-binding peptides were measured for their adhesion antagonistic activity and binding affinity via adhesion inhibition test and non-competitive ELISA, respectively. The results showed that after co-incubated with the mixture of rOmpU and P3, visible green fluorescence could be observed on the epithelioma papulosum cyprinidi (EPC) cells surface; while the EPC cells co-incubated with the mixture of rOmpU and P1/P2 exhibited little green fluorescence. The average adhesion number of V. mimicus 04-14 isolate before and after treatment with peptide was 21.4 ± 1.5, 20.8 ± 0.8 (irrelevant peptide), 20.2 ± 0.5 (P3), 5.1 ± 0.7 (P1) and 3.4 ± 0.8 (P2), respectively. There was a significant decrease in the adhesive level of 04-14 isolate treated with P1/ P2 compared to the untreated isolate (p<0.01). The affinity constants of P1 and P2 were (6.17 ± 0.19) × 108 L/mol and (1.24 ± 0.56) × 109 L/mol, respectively. Furthermore, protective effects of P1 and P2 on grass carps challenged with V. mimicus were preliminary detected. It was found there was delayed death of fish in the groups treated with P1/P2, and the survival rate of challenged fish improved with the increase of the dose of adhesion antagonistic peptide. Taken together, two novel OmpU-binding peptides, which possessed adhesion antagonistic activity, high affinity and a certain degree of antibacterial activity against V. mimicus, were screened and identified.


Assuntos
Adesinas Bacterianas/metabolismo , Antibacterianos/química , Antibacterianos/farmacologia , Doenças dos Peixes/microbiologia , Peptídeos/química , Peptídeos/farmacologia , Vibrio mimicus/efeitos dos fármacos , Animais , Aderência Bacteriana/efeitos dos fármacos , Carpas/microbiologia , Linhagem Celular , Doenças dos Peixes/tratamento farmacológico , Doenças dos Peixes/prevenção & controle , Peixes/microbiologia , Biblioteca de Peptídeos , Vibrio mimicus/metabolismo
3.
Biocontrol Sci ; 19(4): 199-203, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25744216

RESUMO

Of human pathogenic Vibrio species, V. mimicus causes gastroenteritis whereas V. vulnificus causes fatal septicemia after consumption of contaminated seafood. These two pathogens produce hemolytic toxins termed V. mimicus hemolysin (VMH) and V. vulnificus hemolysin (VVH), respectively. These toxins elicit the cytolysis of various eukaryotic cells, as well as erythrocytes. The human intestine secretes cationic antimicrobial peptides (AMPs) to prevent infectious diseases. Paneth cells in the small intestine secrete α-defensin 5 (HD-5) and epithelial cells in the large intestine produce LL-37. In the present study, we examined the bactericidal activities of AMPs against V. mimicus and V. vulnificus. Although HD-5 showed no bactericidal activity, LL-37 revealed significant activity against both Vibrio species, suggesting that neither V. mimicus nor V. vulnificus can multiply in the large intestine. We also tested whether AMPs had the ability to inactivate the hemolytic toxins. Only HD-5 was found to inactivate VMH, but not VVH, in a dose-dependent manner through the direct binding to VMH. Therefore, it is considered that V. mimicus cannot penetrate the small intestinal epithelium because the cytolytic action of VMH is inactivated by HD-5.


Assuntos
Peptídeos Catiônicos Antimicrobianos/metabolismo , Proteínas Hemolisinas/antagonistas & inibidores , Viabilidade Microbiana/efeitos dos fármacos , Vibrio mimicus/efeitos dos fármacos , Vibrio vulnificus/efeitos dos fármacos , Gastroenterite/imunologia , Gastroenterite/microbiologia , Gastroenterite/prevenção & controle , Humanos , Sepse/imunologia , Sepse/microbiologia , Sepse/prevenção & controle , Vibrioses/imunologia , Vibrioses/microbiologia , Vibrioses/prevenção & controle , Vibrio mimicus/imunologia , Vibrio vulnificus/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...